Metaxalone Tablet
Product Images NDC 0276-0508

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metaxalone (NDC 0276-0508). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Misemer Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Mean (SD) Concentrations of Metaxalone following an 800 mg Dose under Fasted and Fed Conditions.)

The image shows a graph with the title "Mean (SD) Concentrations of Metaxalone following an 800 mg Dose under Fasted and Fed Conditions" and the x-axis labeled "Time (hours)" ranging from 0 to 12. The y-axis is labeled "Concentration (ng/mL)" and ranges from 0 to 4000 ng/mL. The graph compares the concentration of metaxalone in the blood after an 800 mg dose under fasted and fed conditions. The graph shows that the mean concentration was higher under fed conditions.*

FDA Label Image

Metaxalone 800 mg (Chemical Structure)

FDA Label Image

Label (Metaxalone)

Each tablet contains 400 mg of metaxalone, USP. The recommended dosage for adults and children over 12 years of age is 400mg tablets (800 mg) up to four times a day. The product is stored at 20°C to 25°C (68°F to 77°F) and is only available with prescription from a healthcare professional. The tablets should be stored in a well-closed, light-resistant container with a child-resistant closure. Manufactured by ScieGen Pharmaceuticals, Inc. in Hauppauge, NY. This information is valid as of September 2021.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.